SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MedImmune

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dr. Bob who wrote (17)3/31/1997 4:41:00 PM
From: bill small   of 416
 
Dr Bob, some questions for you

I am MEDI shareholder and attended last year's annual meeting at which a presentation was given for the RespiGam launch. It was MOST IMPRESSIVE in their marshalling of resources to sell the product but
also reflected a vey human approach to helping doctors and especially
patients in their time of stress with RSV. I thought then as now that
I was a shareholder in a caring company not just another greedy corporate monger. The executives all impressed me that way--unusual
in that I'm not easily impressed. My question to you is have what are
your impression with MEDI as a company, not just from a product viewpoint but from an overall impression in dealing with them.

Second question is, have you any experience or insight into the
MEDI-493 trials ongoing, especially the Phase III one for use with
high risk infants? Would you have any word from MEDI people about
pricing for this product vis a vis RespiGam? Can you comment on how
your this product would be received say at the same price points as
RespiGam?

Finally I too wonder what would keep you from being a MEDI shareholder
Surely not just because you use their product???

you posts are most welcome, please contiue to contribute.....

best regards.....Bill
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext